JPMorgan Chase & Co. reaffirmed their buy rating on shares of Roche (VTX:ROG) in a research report sent to investors on Thursday morning.

A number of other equities research analysts also recently issued reports on the stock. Berenberg Bank set a CHF 260 price target on shares of Roche and gave the company a neutral rating in a research note on Monday, November 20th. set a CHF 203 price target on shares of Roche and gave the company a sell rating in a research note on Friday, October 20th. Deutsche Bank set a CHF 254 price target on shares of Roche and gave the company a neutral rating in a research note on Friday, October 20th. HSBC set a CHF 205 price target on shares of Roche and gave the company a sell rating in a research note on Tuesday, November 21st. Finally, Jefferies Group set a CHF 290 price target on shares of Roche and gave the company a buy rating in a research note on Thursday, November 16th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of CHF 263.42.

Roche (VTX ROG) opened at CHF 245.80 on Thursday. Roche has a 1-year low of CHF 226.10 and a 1-year high of CHF 273. The company has a market cap of $212,060.00 and a price-to-earnings ratio of 21.85.

COPYRIGHT VIOLATION WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2018/01/14/roche-rog-stock-rating-reaffirmed-by-jpmorgan-chase-co.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.